REDHILL BIOPHARMA LTD. (RDHL) Operating income 2015–2024
REDHILL BIOPHARMA LTD. (RDHL) annual operating income history from SEC filings — each fiscal year as reported.
-$14.6MFY2024 · since FY2015: -$22.0M → -$14.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$14.6M | -215.7% |
| FY2023 | $12.6M | +129.5% |
| FY2022 | -$42.8M | +47.2% |
| FY2021 | -$81.1M | -27.4% |
| FY2020 | -$63.7M | -47.4% |
| FY2019 | -$43.2M | -9.8% |
| FY2018 | -$39.3M | +24.3% |
| FY2017 | -$52.0M | -70.2% |
| FY2016 | -$30.5M | -38.8% |
| FY2015 | -$22.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RDHL financial trends
RDHL RevenueRDHL Net incomeRDHL Net marginRDHL Gross profitRDHL Gross marginRDHL Operating marginRDHL Operating cash flowRDHL Free cash flowRDHL Capital expendituresRDHL Return on equityRDHL Stock buybacksRDHL Dividends paidRDHL Total assetsRDHL Total liabilitiesRDHL Shareholders’ equityRDHL overview →